Showing results (101-110 of 146) with videos related to

Sort By:
Pageof 15
Blood|July 1, 2010
Impact of in vivo alemtuzumab dose before reduced intensity conditioning and HLA-identical sibling stem cell transplantation: pharmacokinetics, GVHD, and immune reconstitutionRonjon Chakraverty, Guillermo Orti, Michael Roughton, et al.
Blood Advances|June 20, 2025
Allogeneic hematopoietic stem cell transplantation for STAT3 hyper-IgE syndrome: a worldwide studyChristo Tsilifis, Johannes Raedler, Joanna Renke, et al.
Bone Marrow Transplantation|November 9, 2021
Long-term results and GvHD after prophylactic and preemptive donor lymphocyte infusion after allogeneic stem cell transplantation for acute leukemiaChristoph Schmid, Myriam Labopin, Nicolaas Schaap, et al.
Bone Marrow Transplantation|December 24, 2025
The impact of DNMT3A mutation on survival of AML patients receiving allotransplant in first remission depends on the karyotype and co-occurring mutationsIman Abou Dalle, Jacques-Emmanuel Galimard, Xavier Poire, et al.
Blood|February 9, 2023
Spatial and molecular profiling of the mononuclear phagocyte network in classic Hodgkin lymphomaBenjamin J Stewart, Martin Fergie, Matthew D Young, et al.
Blood Advances|January 4, 2020
Circulating CD1c+ myeloid dendritic cells are potential precursors to LCH lesion CD1a+CD207+ cellsKaren Phaik Har Lim, Paul Milne, Michael Poidinger, et al.
Blood|March 10, 2022
International expert consensus recommendations for the diagnosis and treatment of Langerhans cell histiocytosis in adultsGaurav Goyal, Abdellatif Tazi, Ronald S Go, et al.
Bone Marrow Transplantation|October 16, 2025
Impact of Wilms' tumor 1 gene (WT1) mutation on outcome of allogeneic hematopoietic-cell transplantation for acute myeloid leukemia: a retrospective multicenter cohort study from the ALWP/EBMT registryArnon Nagler, Jordi Esteve, Jacques-Emmanuel Galimard, et al.
The Journal of Allergy and Clinical Immunology|May 31, 2015
Single amino acid charge switch defines clinically distinct proline-serine-threonine phosphatase-interacting protein 1 (PSTPIP1)-associated inflammatory diseasesDirk Holzinger, Selina Kathleen Fassl, Wilco de Jager, et al.
Frontiers in Immunology|October 13, 2023
Organ complications after CD19 CAR T-cell therapy for large B cell lymphoma: a retrospective study from the EBMT transplant complications and lymphoma working partyOlaf Penack, Christophe Peczynski, Christian Koenecke, et al.
Pageof 15